Late-onset cobalamin C deficiency type in adult with cognitive and behavioral disturbances and significant cortical atrophy and cerebellar damage in the MRI: a case report

被引:2
作者
Sun, Miao [1 ]
Dai, Yingjie [1 ]
机构
[1] Gen Hosp Northern Theater Command, Dept Neurol, Shenyang, Peoples R China
来源
FRONTIERS IN NEUROLOGY | 2023年 / 14卷
关键词
methylmalonic acidemia; bilateral cerebellar lesions; reversible DWI change; cblC; MMACHC; METHYLMALONIC ACIDURIA; HOMOCYSTINURIA; DISORDERS; DIAGNOSIS; CBLC;
D O I
10.3389/fneur.2023.1308289
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Late-onset cobalamin C (cblC) deficiency is associated with a wide range of neurological and psychiatric symptoms, hematological manifestations, anorexia, renal failure, ocular abnormalities, dermatitis, and pancreatitis. However, the neuroimaging characteristics of late-onset cblC deficiency remain insufficiently documented. Common findings include diffuse white matter swelling, varying degrees of severe leukoaraiosis, hydrocephalus, corpus callosum atrophy, and symmetric bilateral basal ganglia lesions. In this report, we present a case of late-onset cblC deficiency in adults presenting with cerebellar ataxia as the primary symptom. The MRI findings revealed bilateral lateral cerebellar hemispheres exhibiting symmetric hyperintensity, primarily observed in diffusion-weighted imaging (DWI), which is a rarely reported imaging change in this context.Case presentation: Our patient was a male who experienced symptoms starting at the age of 30 years, including unsteady walking, apparent cerebellar ataxia, and cognitive impairment upon nervous system examination. Brain magnetic resonance imaging (MRI) exhibited symmetric hyperintensity in the bilateral lateral cerebellar hemispheres, predominantly manifested in DWI, without any enhancement. Subsequently, significantly elevated blood total homocysteine and urinary methylmalonic acid levels were observed. Genetic analysis confirmed the presence of MMACHC compound heterozygous mutants c.482G > A and c.609G > A, thus confirming the diagnosis of cblC deficiency. These variants were classified as likely pathogenic following the guidelines of the American College of Medical Genetics and Genomics (ACMG) and were verified using Sanger sequencing. Following treatment, the patient experienced improvements in walking ability and cognition, a significant decrease in blood total homocysteine levels, and reversal of the imaging lesions.In conclusion: Late-onset cblC deficiency presents with diverse clinical and imaging manifestations. Early diagnosis and treatment are crucial in achieving a favorable prognosis. This case serves as a reminder to clinicians not to overlook genetic metabolic disorders, particularly those causing multisite damage, in adult patients with undiagnosed neurological disorders, especially those affecting the cerebellum. Notably, methylmalonic acidemia should be considered within the spectrum of bilateral cerebellar lesions.
引用
收藏
页数:7
相关论文
共 28 条
  • [1] Late-onset cobalamin C disease: rare but treatable
    Aliyar, Aminu
    Endrakanti, Mounika
    Singh, Rajesh K.
    Elavarasi, Arunmozhimaran
    Gupta, Neerja
    Vibha, Deepti
    Tripathi, Manjari
    [J]. PRACTICAL NEUROLOGY, 2022, 22 (05) : 418 - 421
  • [2] Bourque Danielle K, 2021, JIMD Rep, V57, P102, DOI 10.1002/jmd2.12179
  • [3] Adolescent/adult-onset homocysteine remethylation disorders characterized by gait disturbance with/without psychiatric symptoms and cognitive decline: a series of seven cases
    Chang, Kai-Jie
    Zhao, Zhe
    Shen, Hong-Rui
    Bing, Qi
    Li, Nan
    Guo, Xuan
    Hu, Jing
    [J]. NEUROLOGICAL SCIENCES, 2021, 42 (05) : 1987 - 1993
  • [4] Methylmalonic acidemia: Neurodevelopment and neuroimaging
    Chen, Tao
    Gao, Yian
    Zhang, Shengdong
    Wang, Yuanyuan
    Sui, Chaofan
    Yang, Linfeng
    [J]. FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [5] Follow-up study of neuropsychological scores of infant patients with cobalamin C defects and influencing factors of cerebral magnetic resonance imaging characteristics
    Chen, Tao
    Sui, Chaofan
    Lin, Suna
    Guo, Bin
    Wang, Yuanyuan
    Yang, Linfeng
    [J]. FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [6] Late-onset cblC deficiency around puberty: a retrospective study of the clinical characteristics, diagnosis, and treatment
    Chen, Zhehui
    Dong, Hui
    Liu, Yupeng
    He, Ruxuan
    Song, Jinqing
    Jin, Ying
    Li, Mengqiu
    Liu, Yi
    Liu, Xueqin
    Yan, Hui
    Qi, Jianguang
    Wang, Fang
    Xiao, Huijie
    Zheng, Hong
    Kang, Lulu
    Li, Dongxiao
    Zhang, Yao
    Yang, Yanling
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
  • [7] Anti-GAD associated post-infectious cerebellitis after COVID-19 infection
    Emekli, Ahmed Serkan
    Parlak, Asuman
    Gocen, Nejla Yilmaz
    Kurtuncu, Murat
    [J]. NEUROLOGICAL SCIENCES, 2021, 42 (10) : 3995 - 4002
  • [8] Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency
    Huemer, Martina
    Diodato, Daria
    Schwahn, Bernd
    Schiff, Manuel
    Bandeira, Anabela
    Benoist, Jean-Francois
    Burlina, Alberto
    Cerone, Roberto
    Couce, Maria L.
    Garcia-Cazorla, Angeles
    la Marca, Giancarlo
    Pasquini, Elisabetta
    Vilarinho, Laura
    Weisfeld-Adams, James D.
    Kozich, Viktor
    Blom, Henk
    Baumgartner, Matthias R.
    Dionisi-Vici, Carlo
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2017, 40 (01) : 21 - 48
  • [9] Bilateral middle cerebellar peduncle lesions: Neuroimaging features and differential diagnoses
    Jiang, Jiwei
    Wang, Jirui
    Lin, Meiqing
    Wang, Xiaoting
    Zhao, Jinli
    Shang, Xiuli
    [J]. BRAIN AND BEHAVIOR, 2020, 10 (10):
  • [10] Adult-onset CblC deficiency: a challenging diagnosis involving different adult clinical specialists
    Kalantari, Silvia
    Brezzi, Brigida
    Bracciama, Valeria
    Barreca, Antonella
    Nozza, Paolo
    Vaisitti, Tiziana
    Amoroso, Antonio
    Deaglio, Silvia
    Manganaro, Marco
    Porta, Francesco
    Spada, Marco
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)